Immunological Changes after Highly Active Antiretroviral Therapy with Lopinavir–Ritonavir in Heavily Pretreated HIV-Infected Children
- 1 May 2005
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 21 (5) , 398-406
- https://doi.org/10.1089/aid.2005.21.398
Abstract
We evaluated the effect of salvage antiretroviral therapy with lopinavir/ritonavir (LPV/r) on the immune system of heavily antiretroviral pretreated HIV-infected children. We carried out a longitudinal study in 20 antiretroviral experienced HIV-infected children to determine the changes in several immunological parameters (T cell subsets, thymic function) every 3 months during 18 months of follow-up on salvage therapy with LPV/r. Statistical analyses were performed with the Wilcoxon test, taking as a reference the basal value at the entry in the study. HIV-infected children showed an increase of CD4+T cells, a decrease in CD8+ T cells, and an increase in T cell rearrangement excision circle (TRECs) levels. The percentage of HIV children with undetectable viral load (VL ≤400 copies/ml) increased significantly (p = 0.007) and the percentage with SI viral phenotype decreased significantly (p = 0.002) at the end of the study. Thus, the viral phenotype changed to NSI/R5 after salvage therapy with LPV/r. Interestingly, we observed a significant decrease of memory (CD4+ CD45RO+) and a moderate decrease of activated (CD4+ HLA-DR+, CD4+ HLA-DR+CD38, CD4+ , CD45RO+HLA-DR+) CD4+ T cells during the follow-up. On the other hand, memory (CD8+ CD45RO+ and CD8+ CD45RO+CD38+ ), activated (CD8+ HLA-DR+CD38+ , CD8+ HLA-DR+, CD8+ CD38+ ), and effector (CD8+ CD57+, CD8+ CD28−CD57+) CD8+ T cells had a very significant decrease during follow-up. Our data indicate an immune system reconstitution in heavily pretreated HIV-infected children in response to salvage therapy with LPV/r as a consequence of a decrease in immune system activation and an increase in thymic function.Keywords
This publication has 45 references indexed in Scilit:
- CD38 Expression in CD8+T Cells Predicts Virological Failure in HIV Type 1–Infected Children Receiving Antiretroviral TherapyClinical Infectious Diseases, 2004
- Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational StudyClinical Infectious Diseases, 2003
- Positive Regulation of CXCR4 Expression and Signaling by Interleukin-7 in CD4+Mature Thymocytes Correlates with Their Capacity To Favor Human Immunodeficiency X4 Virus ReplicationJournal of Virology, 2003
- Characterizing Immune Reconstitution after Long-Term Highly Active Antiretroviral Therapy in Pediatric AIDSAIDS Research and Human Retroviruses, 2002
- Effects of highly active antiretroviral therapy on thymical reconstitution of CD4 T lymphocytes in vertically HIV-infected childrenAIDS, 2002
- Association of CD8+T Lymphocyte Subsets with the Most Commonly Used Markers to Monitor HIV Type 1 Infection in Children Treated with Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 2001
- Recovery of Replication‐Competent Virus from CD4 T Cell Reservoirs and Change in Coreceptor Use in Human Immunodeficiency Virus Type 1–Infected Children Responding to Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2000
- The Role of the Thymus in Immune Reconstitution in Aging, Bone Marrow Transplantation, and HIV-1 InfectionAnnual Review of Immunology, 2000
- Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1999
- Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapyAIDS, 1998